Heparin Induced Thrombocytopenia (HIT): Further Characterization Of Disease Mechanism Will Improve Patient Treatment
Funder
National Health and Medical Research Council
Funding Amount
$456,484.00
Summary
Thrombus formation occurs as a side effect of heparin treatment in many patients. This condition is called Heparin Induced Thrombocytopenia (HIT). The clots may be stabilised by secretions from cells called neutrophils. In this project we will study this possibility using a mouse model of HIT and will explore therapeutic approaches to inhibit clot stabilisation.
Humanisation And Pre-clinical Validation Of A Therapeutic Anti-cancer Antibody
Funder
National Health and Medical Research Council
Funding Amount
$699,136.00
Summary
This grant will develop a novel antibody against a protease expressed on cancer cells. Preclinical studies, and antibody humanisation, will be performed. This project will also provide vital information on optimal therapeutic approaches with the antibody that can be ultimately taken into human trials.
Signalling Networks As Targets For Antibody Therapy In Glioma.
Funder
National Health and Medical Research Council
Funding Amount
$526,683.00
Summary
Antibodies are a major component of the bodies immune system that bind (i.e. stick) to foreign substances such as viruses. Once bound, these antibodies can activate other parts of the immune system, which help destroy the foreign substance. Analogous to the situation above, a number of institutions are testing antibodies that bind to cancer cells, in order to determine if they are able to destroy these cells. It is also possible to generate antibodies that bind to receptors on the surface of can ....Antibodies are a major component of the bodies immune system that bind (i.e. stick) to foreign substances such as viruses. Once bound, these antibodies can activate other parts of the immune system, which help destroy the foreign substance. Analogous to the situation above, a number of institutions are testing antibodies that bind to cancer cells, in order to determine if they are able to destroy these cells. It is also possible to generate antibodies that bind to receptors on the surface of cancer cells and block their function. If you target a receptor critical to the growth or survival of a cancer cell in this way, then swtiching-off this signal may inhibit tumor growth. In this proposal we plan to test a panel antibodies that recognize receptors important to the growth of brain cancer. Two of these antibodies have been generated and the other two will be made as part of this proposal. A key aspect of this proposal will be testing these antibodies in combination to determine how many receptors need to be targeted in order to get complete tumor regressions in animal models. Overall this work will help us identify new therapeutic strategies for the treatment of brain cancer. Finally, we will also analyze the way different receptors interact together in brain cancer cells.Read moreRead less
We have discovered a single tumour factor which causes cancer cachexia, a wasting condition that is one of the worst complications of malignancy, for which there is no current effective treatment. We have developed antibodies which effectively block this condition in preclinical models and have produced human/humanised version of this. This application is to characterise these human antibodies to allow us proceed to clinical trials.
Alpha-particles linked to recombinant antibodies targeting tumour cells have potential to effectively treat tumours while minimising normal tissue side effects. We will explore a novel alpha-particle therapy approach to solid tumours, by delivering 225Ac directly into tumour cells, or into cells that support the tumour (microenvironment). This approach will hopefully result in development of a new approach to treatment of cancers that are resistant to conventional therapies.
Heparin-induced Thrombocytopenia And Thrombosis: Better Understanding Of Pathogenesis And Improving Diagnosis And Treatment
Funder
National Health and Medical Research Council
Funding Amount
$653,137.00
Summary
Heparin, a widely used drug, can cause an adverse effect which results in a fall of the platelet count and the development of serious thrombosis. This drug complication is mediated by an immune mechanism. This proposal aims to provide a better understanding of the disease mechanism. It also aims to develop a new test that will improve the diagnosis, and to produce a novel drug that will effectively suppress the immune reaction and improve the treatment.
Drug-induced Immune Thrombocytopenia: Understanding The Disease Mechanisms Is The Key To Better Treatment
Funder
National Health and Medical Research Council
Funding Amount
$509,550.00
Summary
Many very commonly used medications cause an allergic reaction in a small number of patients that receive them. The allergic reaction results in platelets being destroyed and puts the patients at risk of bleeding. The patient recovers slowly if the drug is stopped but there is no other treatment and no way to reverse the effect quickly if the patient starts to bleed. This project will try to understand the mechanism of the condition and test a potential treatment.
Industrial Transformation Training Centres - Grant ID: IC150100026
Funder
Australian Research Council
Funding Amount
$3,732,019.00
Summary
ARC Training Centre for Fruit Fly Biosecurity Innovation. ARC Training Centre for Fruit Fly Biosecurity Innovation. This training centre aims to transform the way that horticulture industries combat invasive fruit flies that threaten Australian crops, which are valued at $9 billion per year. For generations, Australia has relied on insecticides to protect crops. Owing to environmental damage and concerns for consumer health, the most effective insecticides have recently been banned for use on ma ....ARC Training Centre for Fruit Fly Biosecurity Innovation. ARC Training Centre for Fruit Fly Biosecurity Innovation. This training centre aims to transform the way that horticulture industries combat invasive fruit flies that threaten Australian crops, which are valued at $9 billion per year. For generations, Australia has relied on insecticides to protect crops. Owing to environmental damage and concerns for consumer health, the most effective insecticides have recently been banned for use on many crops leaving no equivalent replacements. Horticulture industries are unprepared for this change, and are in desperate need of new sustainable practices to combat fruit flies. New researchers who are trained in both scientific approach and practical application will be well placed to deliver these new tools.Read moreRead less
ADAM Metalloprotease Inhibition For Treatment Of Colorectal Cancer
Funder
National Health and Medical Research Council
Funding Amount
$770,925.00
Summary
Colorectal cancer (CRC) causes over 4000 deaths/year, typically from developing drug resistance and spreading to other organs (metastasis). These processes involve tumour cells called cancer stem cells (CSCs), which rely on specific cell surface proteins for survival and function. We are developing antibodies against one of these type of proteins, to test in mouse models of CRC. These already show promise in targeting CSCs and inhibiting drug-resistance and metastasis in mice.
Novel Propagation and Conservation Technologies for Australian Macadamia. Australia’s $850M macadamia industry is a booming contributor to regional growth with a strong domestic market niche. However the industry is threatened by a severe plant supply bottleneck. Also wild germplasm for breeding is threatened with extinction. This project aims to innovate world-first tissue culture technologies for macadamia propagation and secure cryo-storage of germplasm, aided by cutting edge genomics. Expect ....Novel Propagation and Conservation Technologies for Australian Macadamia. Australia’s $850M macadamia industry is a booming contributor to regional growth with a strong domestic market niche. However the industry is threatened by a severe plant supply bottleneck. Also wild germplasm for breeding is threatened with extinction. This project aims to innovate world-first tissue culture technologies for macadamia propagation and secure cryo-storage of germplasm, aided by cutting edge genomics. Expected outcomes of these new, cross-disciplinary techniques are on-demand supply of superior trees to growers and the protection of invaluable germplasm. This should provide significant benefits for industry growth, food security and conservation de-risked from global change.Read moreRead less